ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma

Zhao, Hai-Bo; Zeng, Yan-Ru; Han, Zhao-Dong; Zhuo, Yang-Jia; Liang, Ying-Ke; Hon, Chi Tin; Wan, Song; Wu, Shulin; Dahl, Douglas; Zhong, Wei-De*; Wu, Chin-Lee*广州医学院; 南方医科大学; 1; 5
Cancer Science2021-10DOI: 10.1111/cas.15062
8被引10阅读
引用收藏
分享

摘要

A substantial proportion of prostatic adenocarcinoma (PRAD) patients experience biochemical failure (BCF) after radical prostatectomy (RP). The immune microenvironment plays a vital role in carcinogenesis and the development of PRAD. This study aimed to identify a novel immune-related gene (IRG)-based signature for risk stratification and prognosis of BCF in PRAD. Weighted gene coexpression network analysis was carried out to identify a BCF-related module in a discovery cohort of patients who underwent RP at the Massachusetts General Hospital. The median follow-up time was 70.32 months. Random forest and multivariate stepwise Cox regression analyses were used to identify an IRG-based signature from the specific module. Risk plot analyses, Kaplan-Meier curves, receiver operating characteristic curves, univariate and multivariate Cox regression analyses, stratified analysis, and Harrell's concordance index were used to assess the prognostic value and predictive accuracy of the IRG-based signature in the internal discovery cohort; The Cancer Genome Atlas database was used as a validation cohort. Tumor immune estimation resource database analysis and CIBERSORT algorithm were used to assess the immunophenotype of PRAD. A novel IRG-based signature was identified from the specific module. Five IRGs (BUB1B, NDN, NIDI, COL4A6, and FLRT2) were verified as components of the risk signature. The IRG-based signature showed good prognostic value and predictive accuracy in both the discovery and validation cohorts. Infiltrations of various immune cells were significantly different between low-risk and high-risk groups in PRAD. We identified a novel IRG-based signature that could function as an index for assessing tumor immune status and risk stratification in PRAD.

学科与关键词

关键词
biochemical failureimmune-related risk signatureimmunophenotypeprostatic adenocarcinomarisk stratification
相关
加载中…
  • Development and validation of novel inflammatory response-related gene signature to predict prostate cancer recurrence and response to immune checkpoint therapy
    Luo, Yong; Liu, Xiaopeng; Lin, Jingbo*; Zhong, Weide*; Chen, Qingbiao*Mathematical Biosciences and Engineering, 2022, 19(11): 11345-11366.
  • An Immune-Related lncRNA Signature to Predict the Biochemical Recurrence and Immune Landscape in Prostate Cancer
    Zhang, Guian; Luo, Yong*International Journal of General Medicine, 2021, 14: 9031-9049.被引 1
  • Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer
    Zhang, Guian; Luo, Yong; Dong, Weimin; Zhong, Weide*Computational and Mathematical Methods in Medicine, 2022, 2022: 8233840.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Science
发表日期
2021-10
卷期
第 112 卷, 第 10 期
页码
4365-4376
DOI
10.1111/cas.15062
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81874099, 82072813]; Natural Science Foundation of Guangdong Province [2020A1515010473]; Science and Technology Project of Bureau of Health in Guangzhou Municipality [20171A011239]; Guangzhou Municipal Science and Technology Project [201803040001]; Science Foundation of Guangzhou First People's Hospital [Q2019020, Q2019007]

作者

  • Z

    Zhao, Hai-Bo (第一作者)

    5 · guangzhou med univ · southern med univ

  • Z

    Zeng, Yan-Ru

    1

查看全部 11 位作者收起作者
  • H

    Han, Zhao-Dong

    1 · 2

  • Z

    Zhuo, Yang-Jia

    1 · 2

  • L

    Liang, Ying-Ke

    1 · 2

  • H

    Hon, Chi Tin

  • W

    Wan, Song

    southern med univ

  • W

    Wu, Shulin

  • D

    Dahl, Douglas

  • Z

    Zhong, Wei-De (通讯)

    1 · 2 · southern med univ

  • W

    Wu, Chin-Lee (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417